Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Influenza DNA vaccines.

Jeffrey B Ulmer1

  • 1Chiron Corporation, 4560 Horton St., Emeryville, CA, USA. jeffrey_ulmer@chiron.com

Vaccine
|July 12, 2002
PubMed
Summary

DNA vaccines show promise for inducing immune responses and protection against diseases in animal models. Early research, particularly on influenza DNA vaccines, established this technology as a viable vaccination approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID.

Viruses·2025
Same author

A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross-Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 Variants.

Research square·2025
Same author

A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants.

Human vaccines & immunotherapeutics·2025
Same author

Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19.

Frontiers in immunology·2025
Same author

Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines.

Vaccines·2025
Same author

Dynamics of Spike-Specific Neutralizing Antibodies Across Five-Year Emerging SARS-CoV-2 Variants of Concern Reveal Conserved Epitopes that Protect Against Severe COVID-19.

bioRxiv : the preprint server for biology·2024

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • DNA vaccines have garnered significant research interest due to their potential for broad immune response induction.
  • They have demonstrated efficacy in various animal models for both infectious and non-infectious diseases.
  • Influenza DNA vaccines represent a well-studied area within this field.

Purpose of the Study:

  • To review early research efforts in DNA vaccine technology.
  • To highlight the establishment of DNA vaccines as a novel vaccination strategy.
  • To focus on the development of influenza DNA vaccines.

Main Methods:

  • Review of historical scientific literature on DNA vaccine development.
  • Analysis of studies demonstrating immune responses in animal models.
  • Examination of research specifically pertaining to influenza DNA vaccines.

Main Results:

  • DNA vaccines effectively induce immune responses and protection in preclinical models.
  • Early studies confirmed the feasibility and potential of DNA vaccine technology.
  • Influenza DNA vaccines have been a key focus, showing promising results.

Conclusions:

  • DNA vaccine technology is a validated platform for vaccination.
  • Further development holds potential for combating various diseases.
  • Early work laid the foundation for current DNA vaccine research.

Related Experiment Videos